Impact of plerixafor (mozobil) on hospital efficiency: A single center experience.

about

Plerixafor in poor mobilizers with non-Hodgkin's lymphoma: a multi-center time-motion analysis.

P2860

Q48097743-71454B2E-FA71-4769-AFE7-15D177B216A4

P2860

Impact of plerixafor (mozobil) on hospital efficiency: A single center experience.

Item

http://www.wikidata.org/entity/Q50690379

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Impact of plerixafor (mozobil) on hospital efficiency: A single center experience.

@en

Impact of plerixafor

@nl

type

Item

label

Impact of plerixafor (mozobil) on hospital efficiency: A single center experience.

@en

Impact of plerixafor

@nl

prefLabel

Impact of plerixafor (mozobil) on hospital efficiency: A single center experience.

@en

Impact of plerixafor

@nl

P1476

Impact of plerixafor (mozobil) on hospital efficiency: A single center experience.

@en

P2093

Maya Ouzegdouh

http://www.w3.org/2001/XMLSchema#string

Nabih Azar

http://www.w3.org/2001/XMLSchema#string

Sylvain Choquet

http://www.w3.org/2001/XMLSchema#string

Véronique Leblond

http://www.w3.org/2001/XMLSchema#string

P2860

Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host Disease.

The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone.

Guidelines on the use of extracorporeal photopheresis

The AMD3100 story: the path to the discovery of a stem cell mobilizer (Mozobil).

ESMO Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL).

Optimizing autologous stem cell mobilization strategies to improve patient outcomes: consensus guidelines and recommendations.

Peripheral blood progenitor cell mobilization for autologous and allogeneic hematopoietic cell transplantation: guidelines from the American Society for Blood and Marrow Transplantation.

Plerixafor Salvage Is Safe and Effective in Hard-to-Mobilize Patients Undergoing Chemotherapy and Filgrastim-Based Peripheral Blood Progenitor Cell Mobilization.

Proposed definition of 'poor mobilizer' in lymphoma and multiple myeloma: an analytic hierarchy process by ad hoc working group Gruppo ItalianoTrapianto di Midollo Osseo

Cost-effectiveness analysis of a risk-adapted algorithm of plerixafor use for autologous peripheral blood stem cell mobilization.

P304

5-13

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JCA.21551

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-04-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28455878

http://www.w3.org/2001/XMLSchema#string

Impact of plerixafor (mozobil) on hospital efficiency: A single center experience.

about

P2860

P2860

Impact of plerixafor (mozobil) on hospital efficiency: A single center experience.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698